February 9, 2023 Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia
February 6, 2023 Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis
January 31, 2023 Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood
January 12, 2023 Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial
January 5, 2023 Diagnostic performance of Glial Fibrillary Acidic Protein and Prehospital Stroke Scale for identification of stroke and stroke subtypes in an unselected patient cohort with symptom onset < 4.5 h
November 21, 2022 Brain-specific biomarkers in urine as a non-invasive approach to monitor neuronal and glial damage
November 3, 2022 Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays
October 17, 2022 Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial